Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

BACKGROUND: Dendritic cells (DCs) have been used as vaccines in clinical trials of immunotherapy of cancer and other diseases. Nonetheless, progress towards the use of DCs in the clinic has been slow due in part to the absence of standard methods for DC preparation and exposure to disease-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Markovic, Svetomir N, Dietz, Allan B, Greiner, Carl W, Maas, Mary L, Butler, Greg W, Padley, Douglas J, Bulur, Peggy A, Allred, Jacob B, Creagan, Edward T, Ingle, James N, Gastineau, Dennis A, Vuk-Pavlovic, Stanimir
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570143/
https://www.ncbi.nlm.nih.gov/pubmed/16911798
http://dx.doi.org/10.1186/1479-5876-4-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570143/
https://www.ncbi.nlm.nih.gov/pubmed/16911798
http://dx.doi.org/10.1186/1479-5876-4-35

Ejemplares similares